
    
      The most frequent complication during ECMO is hemorrhage especially as a curative
      anticoagulant treatment is necessary. The primary hemostasis is also affected with a von
      Willebrand disease and thrombopathy, well known but not studied by recent tests.The
      identification of primary haemostasis deficits with these tools would allow to supply them
      and decrease the morbi-mortality related to the transfusion.
    
  